Kawasaki disease and the T-cell antigen receptor

Human Immunology

Volumn 59, Issue 1, 1998, Pages 29-38

  Jason, J ^a   Montana, E ^b   Donald, J Fricks ^a   Seidman, M ^a   Inge, K L ^a   Campbell, R ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR BETA CHAIN;

ANTIGEN EXPRESSION; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOPATHOGENESIS; INFANT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; T LYMPHOCYTE;

ACUTE DISEASE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; FEMALE; FLOW CYTOMETRY; GAMMA-GLOBULINS; HUMANS; INFANT; L-SELECTIN; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; RECEPTOR-CD3 COMPLEX, ANTIGEN, T-CELL; STATISTICS, NONPARAMETRIC;

EID: 0031910729     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(97)00233-4     Document Type: Article

References (44)

1. Bell DM, Morens DM, Holman RC, Hurwitz ES, Hunter MK. Kawasaki syndrome in the United States, 1976 to 1980. Am J Dis Child. 137:1983;211.
2. Kato H, Koike S, Yamamoto M, Ito Y, Yano E. Coronary aneurysms in infants and young children with acute febrile mucocutaneous lymph node syndrome. J Pediatr. 86:1975;892.
3. Suzuki A, Tizard EJ, Gooch V, Dillon MJ, Haworth SG. Kawasaki disease Echocardiographic features in 91 cases presenting in the United Kingdom . Arch Dis Child. 65:1990;1142.
4. Nakamura Y, Fujita Y, Nagai M, Yanagawa H, Imada Y, Okawa S, Kawasaki T, Kato H. Cardiac sequelae of Kawasaki disease in Japan Statistical analysis . Pediatrics. 88:1991;1144.
5. Dhillon R, Newton L, Rudd PT, Hall SM. Management of Kawasaki disease in the British Isles. Arch Dis Child. 69:1993;631.
6. Newburger JW, Takahashi M, Burns JC, Beiser AS, Chung KJ, Duffy CE, Glode MP, Mason WH, Reddy V, Sander SP, Shulman ST, Wiggins JW, Hicks RV, Fulton DR, Lewis AB, Leung DYM, Colton T, Rosen FS, Melish ME. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med. 315:1986;341.
7. Newburger JW, Takahashi M, Beiser AS, Burns JC, Bastian J, Chung KJ, Colan SD, Duffy CE, Fulton DR, Glode MP, Mason WH, Cody-Meissner H, Rowley AH, Shulman ST, Reddy V, Sundel RP, Wiggins JW, Colton T, Melish ME, Rosen FS. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med. 324:1991;1633.
8. Rowley AH, Duffy CE, Shulman St. Prevention of giant coronary artery aneurysms in Kawasaki disease by intravenous gamma globulin therapy. J Pediatr. 113:1988;290.
9. Nagashima M, Matsushima M, matsuoka H, Ogawa A, Okumura N. High-dose gammaglobulin therapy for Kawasaki disease. J Pediatr. 11:1987;710.
10. yanagawa H, Yashiro M, Nakamura Y, Hirose K, Kawasaki T. Nationwide surveillance of Kawasaki disease in Japan, 1984 to 1993. Pediatr Infect Dis J. 14:1995;69.
11. Nakamura Y, Yanagawa H, and Kawasaki T. Temporal and geographical clustering of Kawasaki disease in Japan. In: Shulman St, (ed.): Kawasaki Disease. New York, NY: Alan R. Liss, Inc.: 19, 1987.
12. Tizard EJ, Suzuki A, Levin M, Dillon MJ. Clinical aspects of 100 patients with Kawasaki disease. Arch Dis Child. 66:1991;185.
13. Abe J, Kotzin BL, Jujo K, Melish ME, Glode MP, Kohsaka T, Leung DYM. Selective expansion of T cells expressing T-cell receptor variable regions Vβ2 and Vβ8 in Kawasaki disease. Prov Natl Acad Sci USA. 89:1992;4066.
14. Abe J, Kotzin BL, Meissner C, Melish ME, Takahashi M, Fulton D, Romagné F, Malissen B, Leung DYM. Characterization of T cell repertoire changes in acute Kawasaki disease. J Exp Med. 177:1993;791.
15. Leung DYM, Meissner HC, Fulton Dr Murray DL, Kotzin BL, Schlievert PM. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet. 342:1993;1385.
16. Curtis N, Zheng R, Lamb JR, Levin M. Evidence for a superantigen mediated process in Kawasaki disease. Arch Dis Child. 72:1995;308.
17. Yamashiro Y, Nagata S, Oguchi S, Shimizu T. Selective increase of Vβ2+ T cells in the small intestinal mucosa in Kawasaki disease. Pediatr Res. 39:1996;264.
18. Peitra BA, DeInocencio J, Giannini EH, Hirsch R. TCR Vβ family repertoire and T cell activation markers in Kawasaki disease. J Immunol. 153:1994;1881.
19. Nishiyori A, Sakaguchi M, Kato H, Igarashi H, Miwa K. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet 343:299, 1994 (letter).
20. Sakaguchi M, Kato H, Nishiyori A, Sagawa K, Itoh K. Characterization of CD4+ T helper cells in patients with Kawasaki disease (KD) Preferential production of tumour necrosis factor-alpha (TNF-alpha) by V beta 2- or V beta 8- CD4+ T helper cells . Clin Exp Immunol. 99:1995;276.
21. Choi I-H, Chwae Y-J, Shim W-S, Dong-Soo K, Kwon D-H, Kim J-D, Kim S-J. Clonal expansion of CD8+ T cells in Kawasaki disease. J Immunol. 159:1997;481.
22. Terai M, Miwa K, Williams T, Kabat W, Fukuyama M, Okajima Y, Igarashi H, Shulman ST. The absence of evidence of staphylococcal toxin involvement in the pathogenesis of Kawasaki disease. J Infect Dis. 172:1995;558.
23. Rowley AH, Shulman ST, Preble OT, Poiesz BJ, Ehrlish GD, Sullivan JR. Serum interferon concentrations and retroviral serology in Kawasaki syndrome. Pediatr Infect Dis J. 7:1988;663.
24. Rowley AH, Wolinsky SM, Relman DA, Sambol SP, Sullivan J, Terai M, Shulman ST. Search for highly conserved viral and bacterial nucleic acid sequences corresponding to an etiologic agent of Kawasaki disease. Pediatr Res. 36:1994;567.
25. Rider L, Mendelman P, French J, Sherry D. Group A streptococcal infection and Kawasaki syndrome. Lancet. 337:1991;1100.
26. Hokonohara M, Yoshinaga M, Baba Y. Study of antibody response to 4 streptococcal antigens in rheumatic fever and Kawasaki disease with or without cardiovascular lesions. Jpn Cir. 51:1987;1353.
27. Shulman ST, Rowley AH. Does Kawasaki disease have a retroviral aetiology? Lancet. 2:1986;545.
28. Burns JC, Geha RS, Scheeberger EE, Newburger JW, Rosen FS, Glezen LS, Huang AS, Natale J, Leung DYM. Polymerase activity in lymphocyte culture supernatants from patients with Kawasaki disease. Nature. 323:1986;814.
29. β segments in CD4+ T cells of the virus-positive twins . Proc Natl Acad Sci USA. 91:1994;1529.
30. Diu A, Romagné F, Genevée C, Rocher C, Bruneau J-M, David A, Praz F, Hercend T. Fine specificity of monoclonal antibodies directed at human T cell receptor variable regions Comparison with oligonucleotide-driven amplification for evaluation of Vβ expression . Eur J Immunol. 23:1993;1422.
31. Hall BL, Finn OJ. PCR-based analysis of the T-cell receptor Vβ multigene family Experimental parameters affecting its validity . BioTechniques. 13:1992;248.
32. Jason J, Inge KL. The effects of mitogens, IL-2, and anti-CD3 antibody on the T-cell receptor Vβ repertoire. Scand J Immunol. 43:1996;652.
33. Jason J, Gregg L, Han A, Hu A, Inge KL, Eick A, Tham I, Campbell R. Immunoregulatory changes in Kawasaki disease. Clin Immunol Immunopathol. 84:1997;296-306.
34. Simpson IJ, Skinner MA, Geursen A, Peake JS, Abbott WG, Fraser JD, Lockwood CM, Tan PLJ. Peripheral blood T lymphocytes in systemic vasculitis Increased T cell receptor Vβ2 gene usage in microscopic polyarteritis . Clin Exp Immunol. 101:1995;220.
35. Furukawa K, Mori M, Ohta N, Ideda H, Shida H, Furukawa K, Shiku H. Clonal expansion of CD8+ cytotoxic T lymphocytes against human T cell lymphotropic virus type I (HTLV-I) genome products in HTLV-I-associated myelopathy/tropical spastic paraparesis patients. J Clin Invest. 94:1994;1830.
36. Lehner PJ, Wang EC, Moss PA, Williams S, Platt K, Friedman SM, Bell JI, Borysiewicz LK. Human HLA-A0201-restricted cytotoxic T lymphocyte recognition of influenza A is dominated by T cells bearing the V beta 17 gene segment. J Exp Med. 181:1995;79.
37. Cose SC, Kelly JM, Carbone FR. Characterization of diverse primary herpes simplex virus type I gB-specific cytotoxic T-cell response showing a preferential V beta bias. J Virol. 69:1995;5849.
38. Denkers EY, Caspar P, Sher A. Toxoplasma gondii possesses a superantigen activity that selectively expands murine T cell receptor Vβ5-bearing CD8+ lymphocytes. J Exp Med. 180:1994;985.
39. Bender A, Ernst N, Iglesisas A, Dornmair K, Wekerle H, Hohlfeld R. T cell receptor repertoire in polymyositis clonal expansion of autoaggressive CD8+ Cells . J Exp Med. 181:1995;1863.
40. Hingorani R, Monteiro J, Furie R, Chartash E, Navarrete C, Pergolizzi R, Gregersen PK. Oligoclonality of Vβ TCR chains in the CD8+ cell population of rheumatoid arthritis patients. J Immunol. 156:1996;852.
41. Posnett DN, Sinha R, Kabak S, Russo C. Clonal populations of T cells in normal elderly humans The T cell equivalent to "benign monoclonal gammapathy." J Exp Med. 179:1994;609.
42. Monteiro J, Hingorani R, Choi I-H, Silver J, Pergolizzi R, Gregersen PK. Oligoclonality in the human CD8+ T cell repertoire in normal subjects and monozygotic twins Implications for studies of infectious and autoimmune diseases . Mol Med. 1:1995;614.
43. Jeddi-Tehrani M, Grunewald J, Hodaara V, Andersson R, Wigzell H. Nonrandom T-cell receptor J beta usage pattern in human CD4+ and CD8+ peripheral T cells. Hum Immunol. 40:1994;93.
44. Hingorani R, Choi I-H, Akolkar P, Gulwani-Akolkar B, Pergolizzi R, Silver J, Gregersen PK. Clonal predominance of T cell receptors within the CD8+ CD45RO+ susbset in normal human subjects. J Immunol. 151:1993;5762.